Background: The combination of systemic pulse corticosteroids and methotrexate in the treatment of severe alopecia areata has never been reported.
Objective: The objective of this work was to give arguments for the efficacy and safety of this combined treatment.
Methods: This was a retrospective case series of patients treated with intravenous 500 mg methylprednisolone per day for 3 consecutive days monthly during 3 months plus methotrexate initiated at the end of the second pulse regimen.